Aktuelle smitsomme sygdomme
8 ud af 8 tidsskrifter valgt, ingen søgeord valgt, emner højest 7 dage gamle, sorteret efter nyeste først.
25 emner vises.
ECDC
ECDC Communicable Disease Threats Report, 27.07.2024
Tilføjet 27.07.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20 - 26 July and includes updates on Avian influenza A(H5N6), SARS-CoV-2 variant classification, Overview of respiratory virus epidemiology in the EU/EEA, Circulating vaccine-derived poliovirus type 2 (cVDPV2), cholera, Crimean-Congo haemorrhagic fever, Oropouche virus disease, Seasonal surveillance of West Nile virus infections, Mass gathering monitoring - Olympic and Paralympic Games, Nipah virus disease.
Læs mereMedscape Infectious Diseases, 26.07.2024
Tilføjet 26.07.2024
Especially in the summer, medical professionals should keep an eye out for cases of Lyme disease, anaplasmosis, babesiosis, and Powassan virus, experts urged. Medscape Medical News
Læs mereMedscape Infectious Diseases, 26.07.2024
Tilføjet 26.07.2024
Researchers, clinicians, and patient advocates at a national meeting weighed in on efforts needed to accelerate research on treatments for chronic illness associated with Lyme disease. Medscape Medical News
Læs mereMedscape Infectious Diseases, 26.07.2024
Tilføjet 26.07.2024
The Colorado Department of Public Health and Environment on Thursday announced three additional human cases of bird flu among poultry farm workers, bringing the total number... Reuters Health Information
Læs mereMedscape Infectious Diseases, 26.07.2024
Tilføjet 26.07.2024
The United Nations\' Food and Agriculture Organization on Thursday called for an urgent and unified response to an \'alarming\' rise in avian influenza in humans and animals... Reuters Health Information
Læs mereMira Hleyhel, Julia Geller, Amal Sadou, Paul Naaber, Tatiana Kuznetsova, Sigrid Vorobjov, Marleen Lõhmus, Martina Furegato, Suzanne Reed, Benjamin Bluemel, Erika Duffell and Kristi Rüütel
Eurosurveillance latest updates, 26.07.2024
Tilføjet 26.07.2024
IntroductionObtaining epidemiological data on chronic hepatitis C virus (HCV) infection is essential to monitor progress towards the hepatitis C elimination targets. AimWe aimed to estimate the prevalence of chronic HCV and the seroprevalence of HCV in the adult general population in Estonia. MethodsThis cross-sectional study, conducted between 12 July and 6 December 2022, included anonymised residual sera collected prospectively from patients 18 years and older visiting a general practitioner in all counties of Estonia. Specimens were considered HCV-seropositive if they tested positive for HCV antibodies by enzyme-linked immunoassay, confirmed by line-immunoblot assay. Chronic HCV infection was determined by positive RT-qPCR. ResultsWe tested a total of 4,217 specimens. The estimated HCV seroprevalence and prevalence of chronic HCV infection were 1.8% (95% CI: 1.4–2.2) and 0.8% (95% CI: 0.5–1.1), respectively, with ca 8,100 persons estimated to have chronic HCV infection in the general adult population of Estonia. No statistically significant differences in the prevalence of chronic HCV infection were observed between sexes, counties or age groups, with the highest prevalence rates observed in men (sex ratio: 1.7), Ida-Virumaa County (1.8%; 95% CI: 0.8–3.6) and the age group 40–49 years (1.7%; 95% CI: 0.9–2.9). ConclusionThis study found an overall low prevalence of chronic HCV infection in Estonia. Continued efforts should be made for the targeted screening, diagnosis and treatment of individuals with chronic HCV infection to achieve hepatitis elimination targets.
Læs mereMira Hleyhel, Odette Popovici, Mihaela Leuștean, Suzanne Reed, Amal Sadou, Martina Furegato, Benjamin Bluemel, Erika Duffell and Otilia Mardh
Eurosurveillance latest updates, 26.07.2024
Tilføjet 26.07.2024
IntroductionA national study from 2006 to 2008 showed a high antibody prevalence of 3.2% against hepatitis C virus (HCV) in Romania, but more recent epidemiological data on hepatitis C prevalence are lacking. AimWe aimed to estimate the current prevalence of HCV antibodies (anti-HCV) and chronic HCV infection in the general adult population in Romania, as a crucial element in monitoring progress towards eliminating hepatitis C. MethodsWe used anonymised leftover sera from a SARS-CoV-2 survey conducted between July and October 2020 (n = 2,100), supplemented with sera collected prospectively between July 2022 and March 2023 (n = 574). These included sera collected from adults visiting laboratories for routine medical check-ups. Sera were tested for anti-HCV and HCV core antigen and classified according to anti-HCV and chronic infection status. ResultsOf the total 2,674 specimens tested, 44 were anti-HCV-positive with a weighted anti-HCV prevalence of 1.4% (95% CI: 1.0–1.9), and 29 were HCV core antigen-positive with a weighted prevalence of chronic infection of 0.9% (95% CI: 0.5–1.2). The prevalence of chronic infection did not differ significantly between men and women. It was higher in persons 60 years and older (2.0%; 95% CI: 1.1–3.0) and in specimens from the North-East region (2.2%; 95% CI: 0.8–3.7). ConclusionAlthough the overall HCV prevalence in Romania is currently low, targeted screening, prevention measures and treatment scale-up are needed especially for the population 60 years and older and in the north-eastern part of the country to achieve the goal of ending the hepatitis C epidemic.
Læs mereThomas Ria, Maria Cristina Mancuso, Laura Daprai, Maria Francesca Liporace, Alessandra Gazzola, Sara Arnaboldi, Federica Vianello, Mario Luini, Dario Consonni, Gianluigi Ardissino and on behalf of the ItalKid-HUS Network
Eurosurveillance latest updates, 26.07.2024
Tilføjet 26.07.2024
BackgroundHaemolytic uremic syndrome (HUS) is a severe complication of infection with Shiga toxin-producing Escherichia coli (STEC). Although the reservoirs of STEC are known, the source of the infection of sporadic cases is often unknown. In 2023, we observed several cases of bloody diarrhoea with STEC infection in children and adolescents returning from vacations. AimWe aimed to explore the association between travel and bloody diarrhoea with STEC infection in children and adolescents. MethodsWe included all children and adolescents with bloody diarrhoea with STEC infection identified in 2023 by the ItalKid-HUS Network surveillance system in northern Italy. We interviewed children’s families and sent a questionnaire on recent travels abroad. The exposure time was between 3 days after arrival abroad and 5 days after return home. A self-controlled case series (SCCS) design was used in the analysis. ResultsOf the 43 cases, 11 developed HUS. Twenty-three cases did not travel abroad, while 20 had travelled to several destinations. The incidence rate ratio (IRR) associated with travel to Egypt was 88.6 (95% confidence interval (CI): 17.0–462). Serotype analysis excluded the possibility of a single strain causing the infections. We did not find the source of the infections. ConclusionThere is an elevated risk of acquiring STEC infection with bloody diarrhoea and HUS associated with travel to Egypt. Specific investigations to identify the source are needed to implement effective preventive measures.
Læs mereDiana I Palme , Juliane Lang, Dajana Helke, Maryna Kuryshko and Elsayed M Abdelwhab
Eurosurveillance latest updates, 26.07.2024
Tilføjet 26.07.2024
We investigated the thermostability of four European avian influenza A(H5N1) viruses in whole and semi-skimmed milk and their replication in bovine kidney and lung cells amid the current influenza A(H5N1) dairy cattle outbreak in the United States. Results showed strain-dependent differences in thermal inactivation, particularly in whole milk, and variable replication efficacy in lung cells. These findings support assessing the inactivation of European H5N1 viruses in milk and their replication in bovine cells, aiding biosafety protocols and public health measures.
Læs mereZohar Mor, Husein Omari, Victoria Indenbaum, Oscar D Kirstein, Oren Shatach Catabi, Shay Reicher, Yaniv Lustig, Maya Davidovich-Cohen, Ehud Kaliner, Rivka Sheffer, Shirly Elbaz, Or Kriger and Sharon Alroy-Preis
Eurosurveillance latest updates, 26.07.2024
Tilføjet 26.07.2024
This report describes an unusual surge of West Nile fever in Israel in June 2024, during which 125 cases were diagnosed, compared with 4 cases on average during June in previous years (2014–23). Of the cases, 64 (62.1%) had neuroinvasive disease and 12 (9.6%) died; the 2024 case fatality rate was not significantly elevated vs the average rate in 2014–23. The early rise could be related to a temperature increase in spring and early summer of 2024.
Læs mereMojca Matičič and Maria Buti
Eurosurveillance latest updates, 26.07.2024
Tilføjet 26.07.2024
ECDC
ECDC COVID-19 updates, 26.07.2024
Tilføjet 26.07.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20 - 26 July and includes updates on Avian influenza A(H5N6), SARS-CoV-2 variant classification, Overview of respiratory virus epidemiology in the EU/EEA, Circulating vaccine-derived poliovirus type 2 (cVDPV2), cholera, Crimean-Congo haemorrhagic fever, Oropouche virus disease, Seasonal surveillance of West Nile virus infections, Mass gathering monitoring - Olympic and Paralympic Games, Nipah virus disease.
Læs mereMorbidity and Mortality Weekly Report (MMWR), 25.07.2024
Tilføjet 25.07.2024
This report describes symptom monitoring and testing among exposed dairy and poultry workers in Michigan during the H5N1 outbreak.
Læs mereMorbidity and Mortality Weekly Report (MMWR), 25.07.2024
Tilføjet 25.07.2024
Morbidity and Mortality Weekly Report (MMWR), 25.07.2024
Tilføjet 25.07.2024
This report describes cases of suspected exposure to counterfeit pills containing fentanyl at a hospital in the Western U.S.
Læs mereMorbidity and Mortality Weekly Report (MMWR), 25.07.2024
Tilføjet 25.07.2024
Medscape Infectious Diseases, 25.07.2024
Tilføjet 25.07.2024
A new study showed a newer recombinant shingles vaccine was linked to a 164-day delay in dementia diagnosis in older adults compared to an older live shingles vaccine. Medscape Medical News
Læs mereMedscape Infectious Diseases, 25.07.2024
Tilføjet 25.07.2024
Final results of the highly anticipated PURPOSE 1 trial of lenacapavir show the shots prevent new infections without many side effects. Medscape Medical News
Læs mereMedscape Infectious Diseases, 24.07.2024
Tilføjet 24.07.2024
Merck\'s antibody-based shot met the main goal of a mid-to-late stage trial, when tested to protect infants against a disease caused by the respiratory syncytial virus (RSV),... Reuters Health Information
Læs mereMedscape Infectious Diseases, 24.07.2024
Tilføjet 24.07.2024
Two people have died from an outbreak of the bacteria listeria linked to deli-counter sliced meat, and dozens more have been sickened. WebMD Health News
Læs mereMedscape Infectious Diseases, 24.07.2024
Tilføjet 24.07.2024
Episodes of somnolence and lethargy with recurring alcohol intoxication tormented a 50-year-old woman until the diagnosis of the rare auto-brewery syndrome was considered. Medscape Medical News
Læs mereMedscape Infectious Diseases, 23.07.2024
Tilføjet 23.07.2024
We can\'t just give cash to low-income folks instead of food to improve their health, can we? That\'s just what these researchers did. Medscape
Læs mereMedscape Infectious Diseases, 23.07.2024
Tilføjet 23.07.2024
Ethicist Art Caplan discusses considerations for laboratory-developed meat. Medscape Business of Medicine
Læs mereMedscape Infectious Diseases, 23.07.2024
Tilføjet 23.07.2024
While childhood vaccination rates stagnated for the rest of the world, they increased in Brazil in 2023. Medscape Medical News
Læs mereECDC
ECDC Communicable Disease Threats Report, 20.07.2024
Tilføjet 20.07.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 July 2024 and includes updates on influenza A(H5N1), Measles, Overview of respiratory virus epidemiology in the EU/EEA, ), Cholera, Seasonal surveillance of West Nile virus infections and Mass gathering monitoring.
Læs mere